9Riddle MC,Rosenstock J,Gerich J.Insulin Glargine 4002 Study Investigators.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003; 26(11):3 080-3 086.
10HOE 901/3002 Study Group.Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes[J].Diabetes Care,2000; 23(8):1 130-1 136
1UK Prospective Diabetes Study (UKPDS) Group.Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (U KPDS 33)[J].Lancet,1998,352(9131):837-853.
2The Diabetes Control and Complications Trial Research Group.The absence of a glycemic threshold for the development of long2term complications:the perspective of the Diabetes Control and Complications Trial[J].Diabetes,1996,45(10):1289-1298.
3Mckeage K,Goa K L,Insulin Glargine:a review of its therapeutic use as a long-acting agent for the management of type 1and type2 diabetes mellitus[J].Drugs,2001,61(11):1599-1624.
4C Ronaid Kahn,Gordon C Weir,George L King,et al.Joslin's Diabetes Mellitus[M].北京:人民卫生出版社,2007:681.
